RIM
BSX icon

Reliant Investment Management’s Boston Scientific BSX Stock Holding History

Reliant Investment Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-80,320
Closed -$3.07M – 60
2020
Q3 		$3.07M Buy
80,320
+960
+1% +$37K 1.97% 28
2020
Q2 		$2.79M Buy
79,360
+12,055
+18% +$434K 2.03% 28
2020
Q1 		$2.2M Buy
+67,305
New +$2.63M 2.2% 25

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Reliant Investment Management's BSX Position: Q4 2020 in Review

Reliant Investment Management sold out of Boston Scientific (BSX) in Q4 2020, closing a stake of 80,320 shares — an estimated $3.07M sold.

Reliant Investment Management first reported a position in BSX in Q1 2020 and held it in 3 quarters. The position peaked at $3.07M in Q3 2020. 864 funds tracked by Wall St. Rank hold BSX as of Q4 2020.

  • Reliant Investment Management reported no remaining Boston Scientific position as of Q4 2020 after selling out during the quarter.
  • Reliant Investment Management sold 80,320 Boston Scientific shares in Q4 2020, an estimated $3.07M.
  • Reliant Investment Management first reported a position in Boston Scientific in Q1 2020 and held it in 3 quarters.
  • Reliant Investment Management's Boston Scientific position peaked at $3.07M in Q3 2020.
  • 864 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2020.

Based on Reliant Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.